leisure time -WSS

leisure time

author：hotspot 2025-09-10 10:57:31 - browse：6718

portrait of Jennifer Adair -- coverage from STAT — Jennifer Adair develops scalable, low cost gene therapies at the Fred Hutchinson Cancer Center and helped found the Global Gene Therapy Initiative. Fred Hutch News Service

BALTIMORE — Gene and cell therapies have transformed a handful of devastating disorders in the U.S. and Europe, with more treatments on the way. But those technologies have largely failed to reach most of the world.

These lags are ubiquitous in the current drug development system, where new therapies are approved in wealthy countries and then slowly leak out to low- and middle-income countries, many years later. In the case of gene therapy, that means countries most affected by a disease such as sickle cell may wait decades to access a curative therapy.

For the last few years, a handful of researchers in the U.S. and around the world have tried to find ways of ensuring global access to these technologies. In 2020, they formed the Global Gene Therapy Initiative, with an initial goal of setting up a gene therapy clinical trial for a hemoglobinopathy — such as a disease like sickle cell or beta thalassemia — or HIV in two different low- and middle-income countries by 2024.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Will the FTC rein in IQVIA's health data empire?

focus

WSS

Dems pitch expanding Medicare power to negotiate drug prices

Bronny James, LeBron's son, suffers cardiac arrest during basketball practice at USC

National panel will explore requiring free Covid tests

What causes rare myocarditis in young men after Covid vaccines?

Biogen says it will cut costs by $700 million, slash 1,000 jobs

Vertex non

focus

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

entertainment

ChatGPT in medicine: STAT answers readers' burning questions

CDC Director Mandy Cohen on transparency, trust, and health

Trump demands the U.S. pay no more for drugs than other countries … again

Trump indictment: Who are the 'co

In age of alternative facts, a scholarly course on calling out crap

Truvian presents data for its desktop blood

Dobbs anniversary: the lost opportunity of abortion as health care

STAT Report: Patient voices and perspectives

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

National panel will explore requiring free Covid tests

Wikipedia

Former reverend arrested for allegedly killing 8

Breakthrough Alzheimer’s drugs are inaccessible in rural states

Vertex non

Truvian presents data for its desktop blood

Wildfire pollution widens asthma inequities on Long Island

Mega Millions pot grows to $1.25 billion after no winner

focus

focus

focus

leisure time